Literature DB >> 22691020

In vivo glucose monitoring using dual-wavelength polarimetry to overcome corneal birefringence in the presence of motion.

Casey W Pirnstill1, Bilal H Malik, Vincent C Gresham, Gerard L Coté.   

Abstract

OBJECTIVE: Over the past 35 years considerable research has been performed toward the investigation of noninvasive and minimally invasive glucose monitoring techniques. Optical polarimetry is one noninvasive technique that has shown promise as a means to ascertain blood glucose levels through measuring the glucose concentrations in the anterior chamber of the eye. However, one of the key limitations to the use of optical polarimetry as a means to noninvasively measure glucose levels is the presence of sample noise caused by motion-induced time-varying corneal birefringence. RESEARCH DESIGN AND METHODS: In this article our group presents, for the first time, results that show dual-wavelength polarimetry can be used to accurately detect glucose concentrations in the presence of motion-induced birefringence in vivo using New Zealand White rabbits.
RESULTS: In total, nine animal studies (three New Zealand White rabbits across three separate days) were conducted. Using the dual-wavelength optical polarimetric approach, in vivo, an overall mean average relative difference of 4.49% (11.66 mg/dL) was achieved with 100% Zone A+B hits on a Clarke error grid, including 100% falling in Zone A.
CONCLUSIONS: The results indicate that dual-wavelength polarimetry can effectively be used to significantly reduce the noise due to time-varying corneal birefringence in vivo, allowing the accurate measurement of glucose concentration in the aqueous humor of the eye and correlating that with blood glucose.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22691020      PMCID: PMC3429297          DOI: 10.1089/dia.2012.0070

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  27 in total

Review 1.  Optical glucose sensing in biological fluids: an overview.

Authors:  R J McNichols; G L Coté
Journal:  J Biomed Opt       Date:  2000-01       Impact factor: 3.170

2.  In vivo, transcutaneous glucose sensing using surface-enhanced spatially offset Raman spectroscopy: multiple rats, improved hypoglycemic accuracy, low incident power, and continuous monitoring for greater than 17 days.

Authors:  Ke Ma; Jonathan M Yuen; Nilam C Shah; Joseph T Walsh; Matthew R Glucksberg; Richard P Van Duyne
Journal:  Anal Chem       Date:  2011-11-02       Impact factor: 6.986

3.  Dual-wavelength polarimetry for monitoring glucose in the presence of varying birefringence.

Authors:  Qiujie Wan; Gerard L Coté; J Brandon Dixon
Journal:  J Biomed Opt       Date:  2005 Mar-Apr       Impact factor: 3.170

4.  Alterations of glucose levels in the blood and the anterior eye segment of rabbits exposed to ketamine-xylazine anaesthesia.

Authors:  K Chalabi; M Schütte; M Reim
Journal:  Ophthalmic Res       Date:  1987       Impact factor: 2.892

5.  Real-time, closed-loop dual-wavelength optical polarimetry for glucose monitoring.

Authors:  Bilal H Malik; Gerard L Coté
Journal:  J Biomed Opt       Date:  2010 Jan-Feb       Impact factor: 3.170

6.  Increased glucose content in the aqueous humour caused by the use of xylazine.

Authors:  J Arnbjerg; T Eriksen
Journal:  Ophthalmic Res       Date:  1990       Impact factor: 2.892

7.  ASSESSMENT OF TISSUE OPTICAL CLEARING AS A FUNCTION OF GLUCOSE CONCENTRATION USING OPTICAL COHERENCE TOMOGRAPHY.

Authors:  Narendran Sudheendran; Mohamed Mohamed; Mohamad G Ghosn; Valery V Tuchin; Kirill V Larin
Journal:  J Innov Opt Health Sci       Date:  2010

8.  Investigation of the specificity of Raman spectroscopy in non-invasive blood glucose measurements.

Authors:  Narahara Chari Dingari; Ishan Barman; Gajendra P Singh; Jeon Woong Kang; Ramachandra R Dasari; Michael S Feld
Journal:  Anal Bioanal Chem       Date:  2011-04-21       Impact factor: 4.142

9.  Noninvasive polarimetric-based glucose monitoring: an in vivo study.

Authors:  Georgeanne Purvinis; Brent D Cameron; Douglas M Altrogge
Journal:  J Diabetes Sci Technol       Date:  2011-03-01

10.  Corneal birefringence mapped by scanning laser polarimetry.

Authors:  Robert W Knighton; Xiang-Run Huang; Lora A Cavuoto
Journal:  Opt Express       Date:  2008-09-01       Impact factor: 3.894

View more
  6 in total

1.  Corneal birefringence measured by spectrally resolved Mueller matrix ellipsometry and implications for non-invasive glucose monitoring.

Authors:  Peter Westphal; Johannes-Maria Kaltenbach; Kai Wicker
Journal:  Biomed Opt Express       Date:  2016-03-07       Impact factor: 3.732

2.  Broadband polarimetric glucose determination in protein containing media using characteristic optical rotatory dispersion.

Authors:  Christian Stark; Cesar Andres Carvajal Arrieta; Reza Behroozian; Benjamin Redmer; Felix Fiedler; Stefan Müller
Journal:  Biomed Opt Express       Date:  2019-11-19       Impact factor: 3.732

3.  Label-Free Ultrasensitive Detection of Abnormal Chiral Metabolites in Diabetes.

Authors:  Yaoran Liu; Zilong Wu; Pavana Siddhartha Kollipara; Richard Montellano; Kumar Sharma; Yuebing Zheng
Journal:  ACS Nano       Date:  2021-03-24       Impact factor: 15.881

Review 4.  Non-Invasive Blood Glucose Monitoring Technology: A Review.

Authors:  Liu Tang; Shwu Jen Chang; Ching-Jung Chen; Jen-Tsai Liu
Journal:  Sensors (Basel)       Date:  2020-12-04       Impact factor: 3.576

5.  Glucose-Sensing Photonic Nanochain Probes with Color Change in Seconds.

Authors:  Jinyang Cai; Wei Luo; Juanjuan Pan; Gang Li; Yuyang Pu; Luying Si; Gongpu Shi; Yuxuan Shao; Huiru Ma; Jianguo Guan
Journal:  Adv Sci (Weinh)       Date:  2022-01-31       Impact factor: 16.806

Review 6.  Italian contributions to the development of continuous glucose monitoring sensors for diabetes management.

Authors:  Giovanni Sparacino; Mattia Zanon; Andrea Facchinetti; Chiara Zecchin; Alberto Maran; Claudio Cobelli
Journal:  Sensors (Basel)       Date:  2012-10-12       Impact factor: 3.576

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.